DrugPatentWatch Database Preview
Qilu Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for QILU, and what generic and branded alternatives to QILU drugs are available?
QILU has seventeen approved drugs.
There are three tentative approvals on QILU drugs.
Summary for Qilu
| US Patents: | 0 |
| Tradenames: | 14 |
| Ingredients: | 14 |
| NDAs: | 17 |
| Patent Litigation for Qilu: | See patent lawsuits for Qilu |
Drugs and US Patents for Qilu
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Qilu | CEFEPIME HYDROCHLORIDE | cefepime hydrochloride | INJECTABLE;INJECTION | 203704-003 | Feb 1, 2016 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Qilu | CEFTRIAXONE | ceftriaxone sodium | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | 203702-003 | Jun 29, 2016 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Qilu | IRINOTECAN HYDROCHLORIDE | irinotecan hydrochloride | INJECTABLE;INJECTION | 203380-002 | May 3, 2016 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Qilu | CEFTRIAXONE | ceftriaxone sodium | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | 203702-004 | Jun 29, 2016 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Qilu | CEFAZOLIN SODIUM | cefazolin sodium | INJECTABLE;INJECTION | 209217-001 | Oct 17, 2018 | AP | RX | No | Yes | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
